Swelife reinforces its investment in genomics with SEK eleven million
Swelife reinforces Genomic Medicine Sweden – Vinnova’s initiative in precision medicine – by funding the initiative with SEK eleven million over a two-year period (2020-21).
Genomic Medicine Sweden, GMS is comprised of seven regional Genomic Medicine Centres (GMC) that, in an initial phase, will introduce broad genome sequencing in healthcare. In collaboration with healthcare, academia and industry, GMS coordinates the national introduction of precision medicine. It is a national joining of forces aimed at more patients across Sweden to be given access to broad genome sequencing, which can lead to better diagnostics and more personalised treatments.
“The grant from Swelife improves and supports the possibilities to be able to use genetic data for diagnostics, treatment and prevention of ill-health”, says Peter Nordström, programme director at Swelife. “The project does this by solving issues related to the handling, storage, visualisation and analysis of data. In the long term, the work may also lead to preventative health work becoming more personalised – we are talking about both precision medicine and precision health.”
The funds from Swelife enable healthcare, industry and academia to benefit from data, while preserving the patient’s privacy.
Facts about Genomic Medicine Sweden
Genomic Medicine Sweden, GMS is comprised of seven regional centres for genomic medicine (GMC) that, in an initial phase, will introduce broad genome sequencing in healthcare. This will considerably improve diagnostics and personalised treatments for a series of diseases. Each GMC is a close collaboration between healthcare, universities and SciLifeLab in each region.
In broad collaboration with healthcare, academia and industry, GMS builds infrastructure that enables improved diagnostics, personalised treatment options and research within the area of precision medicine. Initially, GMS is focusing on broad genome sequencing for cancer, rare diagnoses and infectious diseases.
Facts on the funding
The SEK eleven million grant from Vinnova through Swelife is matched with the same amount from Genomic Medicine Sweden’s partners (county councils and universities). The total project budget is therefore SEK 22 million.
The funding contributes to Genomic Medicine Sweden leading the
- development of national standards for storage of genomic data within Swedish healthcare
- development of frameworks for the linking of genomic data and meta data to other health data for analysis and visualisation purposes
- highlighting of legislative changes that must occur to enable secure data sharing at national and international levels
The project will run 2020–21.